Bounce PlayHonestly not much to say here. I have opened a position on this stock as I believe it will bounce to at least $1. Recently dropped from over $4 now sitting at around 0.15 cents. Target is $1.00.
−2.5889USD
−41.658MUSD
18.051MUSD
192.151M
About Avalo Therapeutics, Inc.
Sector
CEO
Garry Arthur Neil
Headquarters
Rockville
Website
Employees (FY)
20
Founded
2011
ISIN
US05338F2074
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
$AVTXinteresting penny that could have some momentum the next couple of days because the unusual volume, so lets see the price breaking above EMA20
Avalo therapeuticsFalling channel playing out if we hold down the red resistance box.
Break support zones and could poss have target at 200% fib ext which will also fill gap.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
